Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials
View/ Open
Date
2008Author
Stevens, Wendy
Kamali, Anatoli
Karita, Etienne
Anzala, Omu
Sanders, Eduard J.
Jaoko Walter G.
Kaleebu, Pontiano
Mulenga, Joseph
Dally, Len
Fast, Pat
Gilmour, Jill
Farah, Bashir
Birung, Josephine
Hughes, Peter
Manigart, Olivier
Stevens, Gwynn
Yates, Sarah
Thomson, Helen
Lieven, Andrea von
Krebs, Marietta
Price, Matt A.
Stoll-Johnson, Lisa
Ketter, Nzeera
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
An understanding of the health of potential volunteers in Africa is essential for the safe and efficient conduct
of clinical trials, particularly for trials of preventive technologies such as vaccines that enroll healthy individuals. Clinical
safety laboratory values used for screening, enrolment and follow-up of African clinical trial volunteers have largely been
based on values derived from industrialized countries in Europe and North America. This report describes baseline morbidity
during recruitment for a multi-center, African laboratory reference intervals study
URI
http://www.ncbi.nlm.nih.gov/pubmed/18446196http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10189
Citation
Screening Lab StudyCollections
- Faculty of Health Sciences (FHS) [10378]